NEW YORK (GenomeWeb News) – GE has launched a new $250 million equity fund to invest in "highly promising" young companies developing or offering life sciences tools, diagnostics, and health care information technologies, GE Healthcare said today.

The GE Healthymagination Fund, part of the company's $6 billion Healthymagination Initiative, will be global in reach and it will harness the capabilities of GE Healthcare, GE Capital, and GE Global Research.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: factors influencing retrotransposon integration sites, and more.

A bioethicist argues for the responsible use of germline gene editing.

Some breweries are using DNA-based testing to determine whether unwanted bacteria are affecting their beers, The Verge reports.

Standardized N-of-1 trials will be needed to test out personalized medicines, writes Nicholas Schork from the J. Craig Venter Institute at Nature.